NasdaqGS - Nasdaq Real Time Price
USD
Organigram Global Inc. (OGI)
1.1800
-0.0300
(-2.48%)
At close: September 1 at 4:00:00 PM EDT
1.1785
-0.0015
(-0.13%)
Pre-Market: 7:08:36 AM EDT
Loading chart for OGI
- Previous Close
1.2100 - Open
1.2000 - Bid 1.1600 x 1000
- Ask 1.2000 x 200
- Day's Range
1.1700 - 1.2100 - 52 Week Range
0.8530 - 2.2400 - Volume
125,412 - Avg. Volume
883,495 - Market Cap (intraday)
166.388M - Beta (5Y Monthly) --
- PE Ratio (TTM)
2.74 - EPS (TTM)
0.4300 - Earnings Date Aug 11, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View More
Performance Overview
Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
OGI
30.59%
S&P/TSX Composite index (^GSPTSE)
12.43%
1-Year Return
OGI
31.79%
S&P/TSX Composite index (^GSPTSE)
25.42%
3-Year Return
OGI
23.38%
S&P/TSX Composite index (^GSPTSE)
74.37%
5-Year Return
OGI
88.70%
S&P/TSX Composite index (^GSPTSE)
73.16%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 9/1/2026
-
Market Cap
170.08M
-
Enterprise Value
184.31M
-
Trailing P/E
2.80
-
Forward P/E
16.84
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
0.74
-
Price/Book (mrq)
0.50
-
Enterprise Value/Revenue
0.83
-
Enterprise Value/EBITDA
14.00
Financial Highlights
Profitability and Income Statement
-
Profit Margin
28.02%
-
Return on Assets (ttm)
-0.60%
-
Return on Equity (ttm)
17.56%
-
Revenue (ttm)
309.18M
-
Net Income Avi to Common (ttm)
86.62M
-
Diluted EPS (ttm)
0.4300
Balance Sheet and Cash Flow
-
Total Cash (mrq)
11.67M
-
Total Debt/Equity (mrq)
3.77%
-
Levered Free Cash Flow (ttm)
421.5k
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
1.1800
-2.48%
Mkt Cap
166.388M
Industry
Drug Manufacturers—Specialty & Generic
9.78
+0.82%
Mkt Cap
2.59B
Industry
Drug Manufacturers—Specialty & Generic
7.54
-2.46%
Mkt Cap
1.648B
Industry
Drug Manufacturers—Specialty & Generic
0.7500
-3.85%
Mkt Cap
279.262M
Industry
Drug Manufacturers—Specialty & Generic
4.0500
0.00%
Mkt Cap
256.406M
Industry
Drug Manufacturers—Specialty & Generic
0.9751
-2.00%
Mkt Cap
463.719M
Industry
Drug Manufacturers—Specialty & Generic
8.84
-0.56%
Mkt Cap
1.7B
Industry
Drug Manufacturers—Specialty & Generic
Mkt Cap
undefined
-
Industry
-
5.96
-3.87%
Mkt Cap
436.379M
Industry
Drug Manufacturers—Specialty & Generic
10.45
-2.52%
Mkt Cap
CAD
2.284B
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
